Precigen (PGEN) EBIT Margin (2016 - 2025)
Precigen (PGEN) has disclosed EBIT Margin for 14 consecutive years, with 681.17% as the latest value for Q3 2025.
- On a quarterly basis, EBIT Margin fell 297234.0% to 681.17% in Q3 2025 year-over-year; TTM through Sep 2025 was 2302.47%, a 513136.0% decrease, with the full-year FY2022 number at 520.06%, up 16895.0% from a year prior.
- EBIT Margin was 681.17% for Q3 2025 at Precigen, up from 93423.53% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 129618.18% in Q4 2024 to a low of 196261.29% in Q2 2024.
- A 5-year average of 14066.61% and a median of 401.83% in 2022 define the central range for EBIT Margin.
- Biggest YoY gain for EBIT Margin was 12893329bps in 2024; the steepest drop was -19562012bps in 2024.
- Precigen's EBIT Margin stood at 697.2% in 2021, then tumbled by -124bps to 166.31% in 2022, then surged by 512bps to 684.89% in 2023, then skyrocketed by 18825bps to 129618.18% in 2024, then crashed by -101bps to 681.17% in 2025.
- Per Business Quant, the three most recent readings for PGEN's EBIT Margin are 681.17% (Q3 2025), 93423.53% (Q2 2025), and 98243.48% (Q1 2025).